SMTL ID : 7mhc.1

Structure of human STING in complex with MK-1454

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.32 Å

Oligo State

homo-dimer

Ligands

2 x ZEV: (2R,5R,7R,8S,10R,12aR,14R,15S,15aR,16R)-7-(2-amino-6-oxo-1,6-dihydro-9H-purin-9-yl)-14-(6-amino-9H-purin-9-yl)-15,16-difluoro-2,10-bis(sulfanyl)octahydro-2H,10H,12H-5,8-methano-2lambda~5~,10lambda~5~-furo[3,2-l][1,3,6,9,11,2,10]pentaoxadiphosphacyclotetradecine-2,10-dione(Non-covalent)

ZEV.1: 24 residues within 4Å: Chain A: S.9, Y.10, G.13, Y.14, R.85, Y.87, E.107, T.110, P.111, T.114 Chain B: S.9, Y.10, G.13, Y.14, I.82, R.85, V.86, Y.87, S.88, E.107, T.110, P.111, T.114 Ligands: ZEV.2 18 PLIP interactions: 6 interactions with chain B, 12 interactions with chain A Hydrogen bonds: B:R.85, B:R.85, B:V.86, A:R.85, A:R.85, A:T.110, A:T.110 Water bridges: B:T.110, A:Y.10, A:T.110 pi-Stacking: B:Y.14, A:Y.14 pi-Cation interactions: B:R.85, A:Y.14, A:R.85 Salt bridges: A:E.107 Halogen bonds: A:R.85, A:R.85 ZEV.2: 24 residues within 4Å: Chain A: S.9, Y.10, G.13, Y.14, I.82, R.85, V.86, Y.87, S.88, E.107, T.110, P.111, T.114 Chain B: S.9, Y.10, G.13, Y.14, R.85, Y.87, E.107, T.110, P.111, T.114 Ligands: ZEV.1 20 PLIP interactions: 13 interactions with chain B, 7 interactions with chain A Hydrogen bonds: B:S.9, B:R.85, B:R.85, B:T.110, B:T.110, A:Y.14, A:R.85, A:R.85, A:V.86, A:T.110 Water bridges: B:T.110, B:T.114 Salt bridges: B:E.107 pi-Stacking: B:Y.14, A:Y.14 pi-Cation interactions: B:Y.14, B:R.85, A:R.85 Halogen bonds: B:R.85, B:R.85

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

McIntosh, J.A. et al., A kinase-cGAS cascade to synthesize a therapeutic STING activator. Nature (2022)

Release Date

2022-04-06

Peptides

Stimulator of interferon genes protein: AB

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
A

Stimulator of interferon genes protein